Century Therapeutics (IPSC) EBT (2020 - 2026)

Century Therapeutics (IPSC) has 7 years of EBT data on file, last reported at -$90.9 million in Q1 2026.

• On a quarterly basis, EBT fell 218.75% year-over-year to -$90.9 million in Q1 2026; TTM through Mar 2026 was -$167.4 million, a 730.63% decrease from a year earlier, with the FY2025 full-year figure at $44000.0, up 100.04% from the prior year.
• EBT for Q1 2026 stood at -$90.9 million, down from -$9.5 million in the prior quarter.
• Over the last five years, EBT for IPSC reached as high as $76.6 million in Q1 2025 and fell as low as -$90.9 million in Q1 2026.
• Historically, EBT has averaged -$28.3 million across 5 years, with a median of -$31.6 million in 2022.
• Across the five-year window, EBT soared 372.83% in 2025 and slumped 218.75% in 2026, its largest moves.
• Year by year, EBT stood at -$31.6 million in 2022, then slipped by 27.23% to -$40.3 million in 2023, then increased by 14.83% to -$34.3 million in 2024, then soared by 72.16% to -$9.5 million in 2025, then slumped by 852.26% to -$90.9 million in 2026.
• Per Business Quant data, the three most recent EBT figures were -$90.9 million in Q1 2026, -$9.5 million in Q4 2025, and -$34.4 million in Q3 2025.